Skip to main content
. 2021 Feb 13;21:72. doi: 10.1186/s12883-021-02102-1

Table 2.

Univariate and multivariate analysis for short- and long-term outcomes after AIS Using IV thrombolysis

Univariate (95% CI) OR Multivariate (95% CI) Adjusted OR
END
 Pre-diabetes 1.20–3.38 1.92 1.12–3.62 2.02
 Diabetes 1.22–3.66 2.11 0.83–2.92 2.02
 Initial hyperglycemia 0.98–2.37 1.53 0.83–2.29 1.38
In-hospital death
 Pre-diabetes 1.34–10.76 3.8 1.06–9.09 3.12
 Diabetes 1.59–12.10 4.38 0.83–7.60 2.52
 Initial hyperglycemia 1.75–7.29 3.59 1.15–5.59 2.54
Poor outcome at 90 days
 Pre-diabetes 0.88–1.86 1.58 0.63–1.51 0.98
 Diabetes 1.45–3.07 2.11 0.97–2.45 1.54
 Initial hyperglycemia 1.30–2.45 1.79 0.91–2.00 1.35
Poor outcome at 1-year
 Pre-diabetes 0.97–2.07 1.41 0.73–1.75 1.13
 Diabetes 1.61–3.40 2.34 1.09–2.78 1.75
 Initial hyperglycemia 1.28–2.41 1.76 0.86–1.89 1.27

Adjusted for Age, sex, baseline NIHSS, stroke subtype, atrial fibrillation, previous stroke, smoking, LDL cholesterol level, onset to needle time, mechanical thrombectomy, and baseline blood glucose level

CI Confidential interval, END Early neurologic deterioration, initial hyperglycemia- more than 140 mg/dl